Menin inhibition with revumenib for NPM1-mutated relapsed or refractory acute myeloid leukemia: the AUGMENT-101 study

Arellano ML, et al.

Citation

Blood. 2025 Aug 28;146(9):1065-1077.

PMID

40332046